GZR18 injection study for people with and without liver problems
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female, with a BMI between 19 and 32.
- You have chronic liver disease (like from hepatitis or alcohol) that is stable, OR you have normal liver function.
- You agree to use birth control for 8 weeks after the last dose if you could become pregnant or get someone pregnant.
- You do not have serious heart problems, pancreatitis, or a history of certain thyroid cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study checks how a new tablet moves through the body and if it is safe for people with mild or moderate liver problems compared to people with healthy livers. It might help doctors understand how to dose the drug for people like you.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This study is for people who finished a previous weight loss trial and want to continue treatment with an injectable medication GZR18. It tests how well the medicine works over a longer period.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.